clefirem
bausch health ireland limited , Írsko - teriflunomid - 59 - immunopraeparata
zoledronic acid mylan
mylan pharmaceuticals limited - kyselina zoledrónová - zlomeniny, kosti - lieky na liečbu chorôb kostí - prevencia kostry súvisiacich udalostí (patologické fraktúry, chrbtice, tlaku, žiarenie alebo chirurgického zákroku na kosti, alebo nádor vyvolaných hypercalcaemia) u dospelých pacientov s pokročilým malignancies zahŕňajú kosti;liečbu dospelých pacientov s nádor vyvolaných hypercalcaemia (tih).
piperacillin/tazobactam mylan 4 g/0,5 g
viatris limited, Írsko - piperacilín a inhibítor betalaktamázy - 15 - antibiotica (proti mikrob. a vÍrusovÝm infekciam)
oramellox 7,5 mg
alpex pharma (irl) limited, Írsko - meloxikam - 29 - antirheumatica, antiphlogistica, antiuratica
tianeptin mylan 12,5 mg
mylan ireland limited, Írsko - tianeptín - 30 - antidepressiva
azacitidine mylan
mylan ireland limited - azacitidín - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastické činidlá - azacitidine mylan is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with:intermediate 2 and high risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29% marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30% blasts and multi lineage dysplasia, according to world health organisation (who) classification,aml with > 30% marrow blasts according to the who classification.
pluvicto
novartis europharm limited - lutetium (177lu) vipivotide tetraxetan - prostatic neoplasms, kastrácia-odolný - terapeutické rádiofarmaká - pluvicto in combination with androgen deprivation therapy (adt) with or without androgen receptor (ar) pathway inhibition is indicated for the treatment of adult patients with progressive prostate-specific membrane antigen (psma)-positive metastatic castration-resistant prostate cancer (mcrpc) who have been treated with ar pathway inhibition and taxane based chemotherapy.
aurorix 150 mg
viatris healthcare limited, Írsko - moklobemid - 30 - antidepressiva
imodium
mcneil healthcare (ireland) limited, Írsko - loperamid - 49 - digestiva, adsorbentia, acida
lacipil 4 mg
glaxosmithkline (ireland) limited, Írsko - lacidipín - 83 - vasodilatantia